Main content

Anti-Biotic Resistance

Antibiotic resistance is a global problem. No new drugs have been produced since the 1980s. So who is to blame? The public's over-consumption or the economics of Pharma companies?

Antibiotic resistance is a global problem but there have been no new drugs produced since the 1980s. So who is to blame? The public's over-consumption or the current economic model for drug research and production? Evan Davis and guests discuss.

GUESTS

Seema Patel, Medical Director, Hospital Business, Pfizer, UK, Ireland and the Nordics

Lord Jim O'Neill, Chair Anti-Microbial Resistance Review (2016), Former Chief Economist, Goldman Sachs

Professor Colin Garner, Co Founder and Director, Antibiotic Research UK

Available now

24 minutes

Last on

Sat 1 Jun 2019 17:30
Βι¶ΉΤΌΕΔ Radio 4

More episodes

Previous

Planning for uncertainty

Next

The Last Mile

See all episodes from The Bottom Line

Broadcast

  • Sat 1 Jun 2019 17:30
    Βι¶ΉΤΌΕΔ Radio 4

Explore further with The Open University

Find out what can help to build sustainable organisations for better business.

Podcast